ArticleImmunoTargets and therapy2023

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer.

Xueping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.